288 related articles for article (PubMed ID: 29807167)
1. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis.
Tan D; Fu Y; Tong W; Li F
Int J Surg; 2018 Jul; 55():128-138. PubMed ID: 29807167
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
3. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.
Nishijima TF; Muss HB; Shachar SS; Tamura K; Takamatsu Y
Cancer Treat Rev; 2015 Dec; 41(10):971-8. PubMed ID: 26481060
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: An up-to-date meta-analysis.
Wu Q; Hu T; Zheng E; Deng X; Wang Z
Medicine (Baltimore); 2017 Jun; 96(22):e7051. PubMed ID: 28562566
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.
Shimura T; Shibata M; Gonda K; Hayase S; Sakamoto W; Okayama H; Fujita S; Saito M; Momma T; Ohki S; Kono K
Fukushima J Med Sci; 2018 Aug; 64(2):64-72. PubMed ID: 30012939
[TBL] [Abstract][Full Text] [Related]
7. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K
World J Gastroenterol; 2015 Sep; 21(34):9966-73. PubMed ID: 26379401
[TBL] [Abstract][Full Text] [Related]
10. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
[TBL] [Abstract][Full Text] [Related]
11. Impact of a lymphocyte to monocyte ratio in stage IV colorectal cancer.
Ozawa T; Ishihara S; Kawai K; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
J Surg Res; 2015 Dec; 199(2):386-92. PubMed ID: 26163330
[TBL] [Abstract][Full Text] [Related]
12. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis.
Gong J; Jiang H; Shu C; Hu MQ; Huang Y; Liu Q; Li RF
J Ovarian Res; 2019 May; 12(1):51. PubMed ID: 31151469
[TBL] [Abstract][Full Text] [Related]
14. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.
Tham T; Olson C; Khaymovich J; Herman SW; Costantino PD
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1663-1670. PubMed ID: 29651542
[TBL] [Abstract][Full Text] [Related]
15. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis.
Ma JY; Liu Q
Int J Surg; 2018 Feb; 50():67-71. PubMed ID: 29329786
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis.
Hu G; Liu G; Ma JY; Hu RJ
Clin Chim Acta; 2018 Nov; 486():44-48. PubMed ID: 30028962
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
[TBL] [Abstract][Full Text] [Related]
20. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
